Skip to content

Medical emergency? What to do

Antibodies show promise in treating Alzheimer's

3-RXPublished July 19, 20063 min read

Key points

  • Researchers say infusing human antibodies into people with Alzheimer's disease appears to help stop the disease from getting worse and may even help the patients improve.
  • Norman Relkin, who led the study says the results suggests that IVIg can exert long-term benefits for the treatment of cognitive decline in Alzheimer's.
  • Scientists estimate that as many as 4.5 million Americans suffer from AD; the disease usually begins after age 60, and the risk increases with age.
  • Alzheimer's is however not a normal part of the aging process.

Researchers say infusing human antibodies into people with Alzheimer's disease appears to help stop the disease from getting worse and may even help the patients improve.

A research team at New York-Presbyterian Hospital/Weill Cornell Medical Center gave six of eight patients intravenous immunoglobulin or IVIg for 18 months and they appeared to develop better brain function.

Dr. Norman Relkin, who led the study says the results suggests that IVIg can exert long-term benefits for the treatment of cognitive decline in Alzheimer's.

The most common form of dementia among older people is Alzheimer's disease (AD) and an estimated 12 million people worldwide are affected.

Scientists estimate that as many as 4.5 million Americans suffer from AD; the disease usually begins after age 60, and the risk increases with age.

While 5 percent of men and women ages 65 to 74 have AD, almost half of those age 85 and older may have the disease.

Alzheimer's is however not a normal part of the aging process.

Alzheimer's initially involves the parts of the brain that control thought, memory, and language and the brains of victims become clogged up with plaques of amyloid proteins and tangles of nerve fibres, but it is still unclear if they are the cause of the disease or a symptom.

Scientists also have found other brain changes in people with AD.

Nerve cells die in areas of the brain that are vital to memory and other mental abilities, and connections between nerve cells are disrupted.

There also are lower levels of some of the chemicals in the brain that carry messages back and forth between nerve cells and impair thinking and memory by disrupting these messages.

The initial stage of the disease is characterised by mild cognitive impairment or memory loss, but as the disease progresses symptoms are more noticeable and forgetfulness begins to interfere with daily activities.

People in the middle stages of may forget how to do simple tasks such as brushing their teeth or combing their hair and can no longer think clearly.

They often do not recognize familiar people and places and begin to have problems speaking, understanding, reading, or writing.

Alzheimer's patients may become anxious or aggressive, or wander away from home and eventually, patients need total care.

Dr. Relkin said his team tested the patients' spinal fluid for amyloid protein and found levels were reduced by more than a third over 18 months and says this indicates the movement of amyloid out of the central nervous system and into the blood stream, where it can be cleared from the body.

IVIg is a mixture of human antibodies, which attach to various foreign invaders such as bacteria and viruses, but also to abnormal cells and proteins and has apparently been used for more than 30 years for a range of disorders.

A major breakthrough is badly needed in new therapies to reduce the disability and suffering of Alzheimer's, and control costs in treating dementia as the world's population is growing rapidly larger and older, and Alzheimer's diagnoses are destined to sharply increase.

The researchers presented their study at the International Conference on Alzheimer's Disease and Related Disorders in Madrid.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underNeurology

Keep reading

Brain

Research Explores Little-Understood Brain Disease

The population of aged persons worldwide is expanding rapidly, and it is becoming increasingly clear that there are many different diseases that affect the minds of these individuals. Researchers at the University of…

3 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.